134 related articles for article (PubMed ID: 9443132)
1. Sulfasalazine-induced fulminant hepatitis in pediatric Crohn's disease: report of two cases.
Besnard M; Debray D; Durand P; Cézard JP; Navarro J
J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):119-20. PubMed ID: 9443132
[No Abstract] [Full Text] [Related]
2. Sulfasalazine-associated encephalopathy in a patient with Crohn's disease.
Schoonjans R; Mast A; Van den Abeele G; Dewilde D; Achten E; Van Maele V; Pauwels W
Am J Gastroenterol; 1993 Oct; 88(10):1759-63. PubMed ID: 8105680
[TBL] [Abstract][Full Text] [Related]
3. Hepatotoxicity after treatment with sulfasalazine.
Haines JD
Postgrad Med; 1986 May; 79(6):193-4, 197-8. PubMed ID: 2871549
[TBL] [Abstract][Full Text] [Related]
4. Holoprosencephaly in a fetus with maternal medication of sulfasalazine in early gestation. A case report.
Koyama N; Komori S; Bessho T; Koyama K; Hiraumi Y; Maeda Y
Clin Exp Obstet Gynecol; 1996; 23(3):136-40. PubMed ID: 8894319
[No Abstract] [Full Text] [Related]
5. Sulfasalazine toxic reactions. Hepatitis, fever, and skin rash with hypocomplementemia and immune complexes.
Mihas AA; Goldenberg DJ; Slaughter RL
JAMA; 1978 Jun; 239(24):2590-1. PubMed ID: 26816
[No Abstract] [Full Text] [Related]
6. [Fulminant hepatitis in two children treated with sulfasalazine for Crohn disease].
Besnard M; Debray D; Durand P; Fabre M; Chardot C; Cézard JP
Arch Pediatr; 1999 Jun; 6(6):643-6. PubMed ID: 10394456
[TBL] [Abstract][Full Text] [Related]
7. Favourable issue of a fulminant hepatitis associated with sulfasalazine DRESS syndrome without liver transplantation.
Descloux E; Argaud L; Dumortier J; Scoazec JY; Boillot O; Robert D
Intensive Care Med; 2005 Dec; 31(12):1727-8. PubMed ID: 16283166
[No Abstract] [Full Text] [Related]
8. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
Haennig A; Bonnet D; Thebault S; Alric L
Gastroenterol Clin Biol; 2010 Sep; 34(8-9):e7-8. PubMed ID: 20189334
[No Abstract] [Full Text] [Related]
9. Sulfasalazine-associated encephalopathy in a patient with Crohn's disease.
Schoonjans R; Mast A; Van Den Abeele G; Dewilde D; Achten E; Van Maele V; Pauwels W
Am J Gastroenterol; 1993 Sep; 88(9):1416-20. PubMed ID: 8103282
[TBL] [Abstract][Full Text] [Related]
10. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
11. Sulfasalazine-induced lupus syndrome in a patient with Crohn's disease.
Carr-Locke DL
Am J Gastroenterol; 1982 Sep; 77(9):614-6. PubMed ID: 6126117
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
Coward S; Kuenzig ME; Hazlewood G; Clement F; McBrien K; Holmes R; Panaccione R; Ghosh S; Seow CH; Rezaie A; Kaplan GG
Inflamm Bowel Dis; 2017 Mar; 23(3):461-472. PubMed ID: 28146003
[TBL] [Abstract][Full Text] [Related]
13. Natalizumab (Tysabri) for Crohn's disease.
Med Lett Drugs Ther; 2008 May; 50(1285):34-6. PubMed ID: 18458669
[No Abstract] [Full Text] [Related]
14. Cholestasis in Crohn's disease: a diagnostic challenge.
Hilzenrat N; Lamoureux E; Sherker A; Cohen A
Can J Gastroenterol; 1997; 11(1):35-7. PubMed ID: 9113796
[TBL] [Abstract][Full Text] [Related]
15. Systemic granulomatous reaction to salicylazosulfapyridine (Azulfidine) in a patient with Crohn's disease.
Rafoth RJ
Am J Dig Dis; 1974 May; 19(5):465-9. PubMed ID: 4151115
[No Abstract] [Full Text] [Related]
16. Anti-inflammatory drug treatment of Crohn's disease: a prospective evaluation of 100 consecutively treated patients.
Goldstein F; Menduke H; Thornton JJ; Abramson J
J Clin Gastroenterol; 1980 Mar; 2(1):77-85. PubMed ID: 6126497
[TBL] [Abstract][Full Text] [Related]
17. Sulfasalazine-induced fulminant hepatic failure.
Marinos G; Riley J; Painter DM; McCaughan GW
J Clin Gastroenterol; 1992 Mar; 14(2):132-5. PubMed ID: 1348259
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
[TBL] [Abstract][Full Text] [Related]
19. Review article: the medical management of Crohn's disease.
Elton E; Hanauer SB
Aliment Pharmacol Ther; 1996 Feb; 10(1):1-22. PubMed ID: 8871440
[TBL] [Abstract][Full Text] [Related]
20. Current status of drug therapy for inflammatory bowel disease.
Peppercorn MA
Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
